Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes.
Florian A WenzlFrancesco BrunoSimon KralerRoland KlingenbergAlexander AkhmedovStefano MinistriniKarine SantosKonstantin GodlyJulia GodlyDavid NiederseerRobert MankaAndreas BergmannGiovanni G CamiciArnold Von EckardsteinBarbara StähliOlivier MüllerMarco RoffiLorenz RäberThomas Felix LüscherPublished in: European heart journal (2023)
This study identifies cDPP3 as a novel marker of CS and increased mortality in patients with ACS. Circulating DPP3 offers prognostic information beyond established risk factors and improves early risk assessment.